What is Prestige Consumer Healthcare's net change in cash?

Prestige Consumer Healthcare (PBH) reported net change in cash of -$56.73M in Q4 2025.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Prestige Consumer Healthcare PBH Net Change in Cash

Net Change in Cash at other companies

Procter & GamblePG

$1.48B+233%

Johnson & JohnsonJNJ

$1.98B-86.2%

HRO

HarrowHROW

$21.72M+11.5%

CencoraCOR

-$2.59B-2,763%

Bausch Health CompaniesBHC

-$13M+70.5%

Cardinal HealthCAH

$1.16B+340%

Other financials

Income statement

See full

Revenue$281.6M-5.0%

Gross profit$146.3M-13.9%

Operating income$75.5M-14.6%

Net income$53.9M+7.6%

EPS (diluted)$1.13+11.9%

Balance sheet

See full

Cash & equivalents$63.9M-34.8%

Total debt$1.0B-0.2%

Total equity$1.9B+2.9%

Total assets$3.5B+2.7%

Cash flow

See full

Operating cash flow$42.8M-30.7%

CapEx$5.2M+49.8%

Free cash flow$37.6M-35.5%

Valuation

See full

Market cap$2.24B-34.1%

Profitability

See full

Gross margin54.7%-1.1pp

Operating margin28.4%-1.2pp

Net margin17.5%-1.4pp

FCF margin22.6%+1.3pp

Returns & leverage

See full

Return on equity10.2%-2.1pp

Debt / equity0.6×0.0×

Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Prestige Consumer Healthcare’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prestige Consumer Healthcare's net change in cash?: Prestige Consumer Healthcare (PBH) reported net change in cash of -$56.73M in Q4 2025.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.